Literature DB >> 11466336

Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.

C J Luckey1, J A Marto, M Partridge, E Hall, F M White, J D Lippolis, J Shabanowitz, D F Hunt, V H Engelhard.   

Abstract

We have studied the contributions of proteasome inhibitor-sensitive and -insensitive proteases to the generation of class I MHC-associated peptides. The cell surface expression of 13 different human class I MHC alleles was inhibited by as much as 90% or as little as 40% when cells were incubated with saturating concentrations of three different proteasome inhibitors. Inhibitor-resistant class I MHC expression was not due to TAP-independent expression or preexisting internal stores of peptides. Furthermore, it did not correlate with the amount or specificity of residual proteasome activity as determined in in vitro proteolysis assays and was not augmented by simultaneous incubation with multiple inhibitors. Mass spectrometry was used to directly characterize the peptides expressed in the presence and absence of proteasome inhibitors. The number of peptide species detected correlated with the levels of class I detected by flow cytometry. Thus, for many alleles, a significant proportion of associated peptide species continue to be generated in the presence of saturating levels of proteasome inhibitors. Comparison of the peptide-binding motifs of inhibitor-sensitive and -resistant class I alleles further suggested that inhibitor-resistant proteolytic activities display a wide diversity of cleavage specificities, including a trypsin-like activity. Sequence analysis demonstrated that inhibitor-resistant peptides contain diverse carboxyl termini and are derived from protein substrates dispersed throughout the cell. The possible contributions of inhibitor-resistant proteasome activities and nonproteasomal proteases residing in the cytosol to the peptide profiles associated with many class I MHC alleles are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466336     DOI: 10.4049/jimmunol.167.3.1212

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  The origin of proteasome-inhibitor resistant HLA class I peptidomes: a study with HLA-A*68:01.

Authors:  Noel García-Medel; Alejandro Sanz-Bravo; Eilon Barnea; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2011-10-03       Impact factor: 5.911

2.  Immunopeptidomic Analysis Reveals That Deamidated HLA-bound Peptides Arise Predominantly from Deglycosylated Precursors.

Authors:  Shutao Mei; Rochelle Ayala; Sri H Ramarathinam; Patricia T Illing; Pouya Faridi; Jiangning Song; Anthony W Purcell; Nathan P Croft
Journal:  Mol Cell Proteomics       Date:  2020-05-01       Impact factor: 5.911

3.  The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.

Authors:  Victor H Engelhard
Journal:  Int J Mass Spectrom       Date:  2007-01-01       Impact factor: 1.986

Review 4.  Generation of MHC class I ligands in the secretory and vesicular pathways.

Authors:  Margarita Del Val; Salvador Iborra; Manuel Ramos; Silvia Lázaro
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

5.  Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.

Authors:  Elena Lorente; Ruth García; Daniel López
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

6.  Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.

Authors:  Jiajie Wei; Rigel J Kishton; Matthew Angel; Crystal S Conn; Nicole Dalla-Venezia; Virginie Marcel; Anne Vincent; Frédéric Catez; Sabrina Ferré; Lilia Ayadi; Virginie Marchand; Devin Dersh; James S Gibbs; Ivaylo P Ivanov; Nathan Fridlyand; Yohann Couté; Jean-Jacques Diaz; Shu-Bing Qian; Louis M Staudt; Nicholas P Restifo; Jonathan W Yewdell
Journal:  Mol Cell       Date:  2019-01-31       Impact factor: 17.970

7.  The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome.

Authors:  Elena Milner; Lilach Gutter-Kapon; Michal Bassani-Strenberg; Eilon Barnea; Ilan Beer; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2013-03-28       Impact factor: 5.911

8.  Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers.

Authors:  Haseeb Ilias Basha; Venkataswarup Tiriveedhi; Timothy P Fleming; William E Gillanders; T Mohanakumar
Journal:  Breast Cancer Res Treat       Date:  2010-06-11       Impact factor: 4.872

Review 9.  Proteases in MHC class I presentation and cross-presentation.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Lianjun Shen
Journal:  J Immunol       Date:  2010-01-01       Impact factor: 5.422

10.  Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma.

Authors:  Jumei Shi; Guido J Tricot; Tarun K Garg; Priyangi A Malaviarachchi; Susann M Szmania; Rachel E Kellum; Brian Storrie; Arend Mulder; John D Shaughnessy; Bart Barlogie; Frits van Rhee
Journal:  Blood       Date:  2007-10-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.